OCUL
#1895
Ocular Therapeutix, Inc. - Common Stock
10.8 2 USD
0.00%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.46%
Monthly Change
+27.14%
6 month change
+24.08%
Year Change
-5.91%
Previous Close
10.7 7
Open
10.8 2
Low
10.8 2
High
10.8 2
Volume
85
Financials
- Market Capitalization 2.38 B
- Employee 325
- Founded 2006
- CEO Pravin Dugel
- Website www.ocutx.com
- Headquarter Delaware, United States
- FIGI BBG001J1BZV0
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-8.55
Price to sales ratio
43.75
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1882 |  BHVN Biohaven Ltd. Common Shares | 16.12 USD | -5.01% | +17.66% | +16.56% | -4.85% | 2.43 B USD | ||
| 1887 |  PHVS Pharvaris N.V. - Ordinary Shares | 37.00 USD | 0.00% | +1.07% | +10.78% | +62.07% | 2.41 B USD | ||
| 1900 |  MESO Mesoblast Limited - American Depositary Shares | 18.18 USD | +7.96% | +7.07% | +26.78% | +27.85% | 2.36 B USD | ||
| 1913 |  HRMY Harmony Biosciences Holdings, Inc. - Common Stock | 39.87 USD | +0.53% | +4.59% | +11.71% | +29.03% | 2.32 B USD |
Frequently asked questions about Ocular Therapeutix, Inc.
What is the Ocular Therapeutix, Inc. stock price today?
The current price of Ocular Therapeutix, Inc. (OCUL) is 10.82. Over the past 24 hours, the stock has changed by +0.46%. Follow the OCUL chart for real-time price dynamics.
What is the stock ticker of Ocular Therapeutix, Inc.?
Ocular Therapeutix, Inc. trades under the ticker OCUL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Ocular Therapeutix, Inc. stock going up?
OCUL has changed by -2.87% over the last week, +27.14% over the last month, and -5.91% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Ocular Therapeutix, Inc.?
Ocular Therapeutix, Inc. currently has a market capitalization of 2.38 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Ocular Therapeutix, Inc. earnings last quarter?
Last quarter, Ocular Therapeutix, Inc. reported earnings of -0.35 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Ocular Therapeutix, Inc. revenue for the last quarter?
Ocular Therapeutix, Inc. reported quarterly revenue of 13.47 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Ocular Therapeutix, Inc. net income for the last quarter?
Ocular Therapeutix, Inc. reported net income of -78.76 M for the last quarter. The previous quarter showed -88.61 M, which means net income changed by +11.11%.
How many employees does Ocular Therapeutix, Inc. have?
As of the latest available data, Ocular Therapeutix, Inc. has 325 employees. Workforce size can provide additional context about the company's scale and operations.
What is Ocular Therapeutix, Inc. EBITDA?
Ocular Therapeutix, Inc. EBITDA is -80.26 M, and its EBITDA margin is -595.61%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Ocular Therapeutix, Inc. stock?
You can buy Ocular Therapeutix, Inc. (OCUL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Ocular Therapeutix, Inc. stock?
Investing in Ocular Therapeutix, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the OCUL chart and related analysis on metatrader.com as part of your research.